HMS
TGTX icon

Hanseatic Management Services’s TG Therapeutics TGTX Stock Holding History

Hanseatic Management Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-274
Closed -$11K – 171
2021
Q2 		$11K Hold
274
– – 0.02% 108
2021
Q1 		$13K Hold
274
– – 0.03% 109
2020
Q4 		$14K Hold
274
– – 0.03% 114
2020
Q3 		$7K Buy
274
+95
+53% +$2.19K 0.02% 151
2020
Q2 		$3K Hold
179
– – ﹤0.01% 162
2020
Q1 		$2K Buy
+179
New +$2.26K ﹤0.01% 191
2018
Q3 		– Sell
-114
Closed -$1K – 431
2018
Q2 		$1K Hold
114
– – ﹤0.01% 368
2018
Q1 		$2K Buy
+114
New +$1.46K ﹤0.01% 348

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hanseatic Management Services's TGTX Position: Q3 2021 in Review

Hanseatic Management Services sold out of TG Therapeutics (TGTX) in Q3 2021, closing a stake of 274 shares — an estimated $11K sold.

Hanseatic Management Services first reported a position in TGTX in Q1 2018 and held it in 8 quarters. The position peaked at $14K in Q4 2020. 222 funds tracked by Wall St. Rank hold TGTX as of Q3 2021.

  • Hanseatic Management Services reported no remaining TG Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Hanseatic Management Services sold 274 TG Therapeutics shares in Q3 2021, an estimated $11K.
  • Hanseatic Management Services first reported a position in TG Therapeutics in Q1 2018 and held it in 8 quarters.
  • Hanseatic Management Services's TG Therapeutics position peaked at $14K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2021.

Based on Hanseatic Management Services's 13F filing for Q3 2021, filed 5 Oct 2021.